February 27, 2021 1:02 AM
Latest:
  • Ayr Wellness Closes On Liberty Health Acquisition
  • Teladoc: Mixed Results From Analysts Following Q4 Results
  • GameStop Short-Sellers Lose Another $2 Billion Amid Retail Trading Resurgence
  • Silver Is Too Big To Squeeze – The Daily Dive feat Ryan Giannotto of GraniteShares
  • Antibe: Canaccord Lowers Price Target After Co-Leading $40.4 Million Financing
The Deep Dive

the deep dive

Providing stock analysis for investors of the Canadian junior markets

Thank you!

You have successfully joined our subscriber list.

.

  • Home
  • Latest
    • Automotive
    • Briefing
    • Cannabis
    • Commentary
    • Education
    • Full Analysis
    • Gold
    • Industrials
    • Macro
    • Oil
    • Psychedelics
    • Resources
    • Technology
  • Cannabis
  • Technology
  • Company Profiles
    • Cannabis
      • Pure Extracts
      • Tinley Beverage Co
    • Mining
      • AUX Resources
      • Freeman Gold
      • Newlox Gold Ventures
      • Noram Ventures
      • Riverside Resources
      • SKRR Exploration Inc.
      • Spruce Ridge Resources
    • Technology
      • CloudMD
      • Datametrex AI Limited
      • MustGrow Biologics
      • PowerBand Solutions
      • Revive Therapeutics
  • Resources
  • About
  • Contact Us
  • Advertise With Us

Pharmather

Briefing News Psychedelics 

PharmaTher Collaborates For Research On Psychedelic Microdosing Tech

February 23, 2021 7:25 AMFebruary 23, 2021 7:25 AM Jay Lutz 0 Comments Pharmather

PharmaTher Inc (CSE: PHRM) this morning announced that it will be conducting further research related to psychedelics. The company this

Share
Tweet
Share
Read more
Briefing News Psychedelics 

PharmaTher, Revive, Complete Psilocybin Intellectual Property Transaction

February 17, 2021 9:58 AMFebruary 17, 2021 9:58 AM Jay Lutz 0 Comments Pharmather, Revive Therapeutics

PharmaTher (CSE: PHRM) has seen the completion of the sale of its psilocybin program to that of Revive Therapeutics (CSE:

Share
Tweet
Share
Read more
Briefing News Psychedelics 

PharmaTher To Commence Phase 2 Clinical Study On Ketamine In Q2 2021

February 4, 2021 8:28 AMFebruary 4, 2021 8:28 AM Jay Lutz 0 Comments Pharmather

Pharmather Inc (CSE: PHRM) is successfully progressing on the development of its proposed phase 2 clinical study on ketamine in

Share
Tweet
Share
Read more
Briefing News Psychedelics 

PharmaTher Licenses Patented Microneedle Delivery Tech For Ketamine

February 1, 2021 8:13 AMFebruary 1, 2021 8:14 AM Jay Lutz 0 Comments Pharmather

PharmaTher Inc (CSE: PHRM) this morning announced that it has entered into an exclusive worldwide patent and know-how license agreement

Share
Tweet
Share
Read more
Briefing News Psychedelics 

PharmaTher Acquires Exclusive Rights To Patented Ketamine Formulation

January 19, 2021 9:24 AMJanuary 19, 2021 9:24 AM Jay Lutz 0 Comments Ketamine, Pharmather

PharmaTher Inc (CSE: PHRM) has entered into an exclusive worldwide license agreement for the development and commercialization of a patented

Share
Tweet
Share
Read more
Briefing News Psychedelics 

Revive Therapeutics Enters LOI To Acquire Psilocybin Program From PharmaTher

December 21, 2020 8:38 AMDecember 21, 2020 9:11 AM Jay Lutz 0 Comments Pharmather, Psilocybin, Revive Therapeutics

Revive Therapeutics (CSE: RVV) this morning announced that it has entered into a letter of intent to acquire PharmaTher Inc’s

Share
Tweet
Share
Read more
Briefing News Psychedelics 

PharmaTher Files Patent Application In US For Psilocybin Drug Combination To Treat Neurological Disorders

December 15, 2020 9:00 AMDecember 15, 2020 9:00 AM Jay Lutz 0 Comments Pharmather

PharmaTher Inc (CSE: PHRM) this morning announced that it has filed a provisional patent application with the US Patent and

Share
Tweet
Share
Read more
Briefing Psychedelics 

FDA Grants PharmaTher Pre-IND Meeting For Treatment Of Parkinson’s With Ketamine

December 10, 2020 9:04 AMDecember 10, 2020 9:04 AM Jay Lutz 0 Comments FDA, Pharmather

PharmaTher Inc (CSE: PHRM) this morning announced that the US Food and Drug Administration has granted the company a pre-investigational

Share
Tweet
Share
Read more
Briefing News Psychedelics 

PharmaTher Files With FDA For Pre-IND Meeting On Use Of Ketamine In Treatment Of Parkinson’s Disease

December 8, 2020 9:08 AMDecember 8, 2020 9:08 AM Jay Lutz 0 Comments Pharmather

PharmaTher Inc (CSE: PHRM) this morning announced that it has filed a pre-investigational new drug meeting request, as well as

Share
Tweet
Share
Read more
Briefing Psychedelics Technology 

PharmaTher To Develop Digital Therapeutics Platform Focused On Psychedelic Therapies

December 1, 2020 7:36 AMDecember 1, 2020 7:36 AM Jay Lutz 0 Comments Pharmather

Pharmather Inc (CSE: PHRM) this morning announced that it has amended its sponsored research agreement with that of the University

Share
Tweet
Share
Read more
  • ← Previous

Briefings

Ayr Wellness Closes On Liberty Health Acquisition
Briefing Cannabis 

Ayr Wellness Closes On Liberty Health Acquisition

February 26, 2021 4:46 PM Jay Lutz 0

Ayr Wellness (CSE: AYR.a) this afternoon announced that it has closed on the acquisition of Liberty Health Sciences (CSE: LHS).

Teladoc: Mixed Results From Analysts Following Q4 Results
Briefing Healthcare 

Teladoc: Mixed Results From Analysts Following Q4 Results

February 26, 2021 4:06 PM Justin Young 0
GameStop Short-Sellers Lose Another $2 Billion Amid Retail Trading Resurgence
Briefing Macro 

GameStop Short-Sellers Lose Another $2 Billion Amid Retail Trading Resurgence

February 26, 2021 2:45 PM Hermina Paull 0
Silver Is Too Big To Squeeze – The Daily Dive feat Ryan Giannotto of GraniteShares
Briefing Macro Resources Video Series 

Silver Is Too Big To Squeeze – The Daily Dive feat Ryan Giannotto of GraniteShares

February 26, 2021 1:30 PM Jay Lutz 0
Antibe: Canaccord Lowers Price Target After Co-Leading $40.4 Million Financing
Biotech Briefing 

Antibe: Canaccord Lowers Price Target After Co-Leading $40.4 Million Financing

February 26, 2021 11:55 AM Justin Young 0
Coinbase Files Listing To Go Public On Nasdaq Amid Bitcoin Boom
Blockchain Briefing 

Coinbase Files Listing To Go Public On Nasdaq Amid Bitcoin Boom

February 26, 2021 10:46 AM Hermina Paull 0
Cineplex Closes $250 Million Secured Note Financing
Briefing Entertainment 

Cineplex Closes $250 Million Secured Note Financing

February 26, 2021 9:31 AM Jay Lutz 0

Spotlight Series

Silver Is Too Big To Squeeze – The Daily Dive feat Ryan Giannotto of GraniteShares
Briefing Macro Resources Video Series 

Silver Is Too Big To Squeeze – The Daily Dive feat Ryan Giannotto of GraniteShares

February 26, 2021 1:30 PM Jay Lutz 0

Joining us for the final episode of The Daily Dive during the trading week is that of Ryan Giannotto, Director

News

Revive Therapeutics To Expand Clinical Sites For Covid-19 Related Phase 3 Study
Briefing Healthcare News 

Revive Therapeutics To Expand Clinical Sites For Covid-19 Related Phase 3 Study

February 26, 2021 8:54 AM Jay Lutz 0

Revive Therapeutics (CSE: RVV) this morning provided an update on the status of its phase 3 clinical trial for the

Exploits Discovery Looks To Raise $4.0 Million
Briefing News Resources 

Exploits Discovery Looks To Raise $4.0 Million

February 26, 2021 7:41 AM Jay Lutz 0
Stem Holdings: Beacon Initiates With $3.00 Price Target, Buy Rating
Briefing Cannabis News 

Stem Holdings: Beacon Initiates With $3.00 Price Target, Buy Rating

February 25, 2021 11:07 AM Justin Young 0
Pure Extracts Sees Products Submitted To Health Canada For Approval
Briefing Cannabis News 

Pure Extracts Sees Products Submitted To Health Canada For Approval

February 25, 2021 7:53 AM Jay Lutz 0

About

Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions. We take a closer look at all data relating to organizations listed on the CSE and the TSX Venture to create quality stock analysis for investors.

Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security.

Need some freelance work done? We’re experienced in many forms of writing, including press releases. Shoot us an email & let’s chat!

Menu

  • Home
  • About
  • Research
  • Discover
  • Contact Us
  • Disclaimer

Categories

  • Automotive
  • Biotech
  • Blockchain
  • Bonds
  • Briefing
  • Cannabis
  • Commentary
  • Education
  • Energy
  • Entertainment
  • Esports
  • Food
  • Full Analysis
  • Healthcare
  • Industrials
  • Macro
  • Market Movers
  • Mental Hurdles
  • News
  • Oil
  • Psychedelics
  • Resources
  • Retail
  • SPACs
  • Technology
  • Video Series
Copyright © 2021 the deep dive. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.